Homophobic legislation and its Impact on Human Security

This report by the MSMGF explores the circumstances around the enactment of new anti-homosexual legislation in Nigeria and Uganda, examining five categories of insecurity faced by lesbian, gay, bisexual and transgender (LGBT) people in the context of these laws.

Data and Uncertainty: Understanding updates on hormonal contraceptives and HIV

AIDS 2014 featured analyses of data on the potential relationship between hormonal contraceptives and risk of HIV infection. Researchers Charles Morrison (FHI 360) and Kristin Wall (Emory University), and Mary Lyn Gaffield from the WHO discussed the newest findings and guidance.

Creating a Prevention Agenda for Women: AVAC/CHANGE meeting for coordinated global advocacy

This report, released by CHANGE and cosponsored by AVAC, summarizes the key recommendations related to integration of HIV and family planning services, how to best move forward in the context of uncertainty about whether some hormonal contraceptives (HC) increase HIV risk, and how to advance “method mix”—a wider array of contraceptive choices for women everywhere.

Facing Questions about Hormonal Contraceptives and HIV: What’s next in getting answers?

In this webinar we learned about and discussed proposed research to directly evaluate how different family planning methods might impact HIV risk.

Trial designs are actively being discussed and funding is being sought for such research—but there are many questions where advocates’ voices are needed: What should a trial look like? How can method mix (the range of available family planning options) be expanded for all women? What can be done to better integrate HIV and family planning in the meantime?

View the full webinar here

Rectal Microbicides Video Facilitator’s Guide

This guide is meant to be used as a preparation tool for people leading community discussions, workshops, or recruitment sessions who will be showing the educational video. Background information on rectal microbicide research and the clinical trial process is included in the guide.

Rectal Microbicides Video Facilitator’s Guide (Spanish)

This guide is meant to be used as a preparation tool for people leading community discussions, workshops, or recruitment sessions who will be showing the educational video in Spanish. Background information on rectal microbicide research and the clinical trial process is included in the guide.

Rectal Microbicides Video Facilitator’s Guide (Thai)

This guide is meant to be used as a preparation tool for people leading community discussions, workshops, or recruitment sessions who will be showing the educational video in Thai. Background information on rectal microbicide research and the clinical trial process is included in the guide.

The GLAM Toolkit: Advocacy to improve access to safe, condom-compatible lubricant in Africa

The GLAM Toolkit: Advocacy to improve access to safe, condom-compatible lubricant in Africa” published by IRMA, amfAR and AVAC, provides background on the status of lubricant (lube) access in Africa and suggests potential strategies for civil society and government partners to secure and distribute sustainable supplies of safe, condom-compatible lube. Global Lube Access Mobilisation (GLAM) is a campaign of IRMA’s Project ARM (Africa for Rectal Microbicides) initiative.

The GLAM Toolkit: Advocacy to improve access to safe, condom-compatible lubricant in Africa (French)

“La boîte à outils GLAM – Plaidoyer pour améliorer l’accès en Afrique à du lubrifiant fiable et adapté au préservatif”, published by IRMA, amfAR and AVAC, provides background on the status of lubricant (lube) access in Africa and suggests potential strategies for civil society and government partners to secure and distribute sustainable supplies of safe, condom-compatible lube. Global Lube Access Mobilisation (GLAM) is a campaign of IRMA’s Project ARM (Africa for Rectal Microbicides) initiative.

MTN-017 Trial Launch Webinar

Be the Generation Bridge and International Rectal Microbicide Advocates (IRMA) hosted a webinar to mark the launch of MTN-017, the first-ever phase II safety study of a rectal microbicide. Ross D. Cranston, MD, of the University of Pittsburgh School of Medicine and co-leader of MTN-017, presented on the trial details, followed by Jim Pickett of IRMA who presented on the community engagement activities undertaken in support of the trial.